0.89
price down icon8.66%   -0.0844
after-market After Hours: .90 0.01 +1.12%
loading
Conduit Pharmaceuticals Inc stock is traded at $0.89, with a volume of 900.70K. It is down -8.66% in the last 24 hours and down -24.58% over the past month. Conduit Pharmaceuticals Inc is a clinical-stage specialty biopharmaceutical company that was formed to facilitate the development and commercialization of clinical assets that have not been or are not being, prioritized by biopharmaceutical companies to develop pharmaceutical products that meet the unmet medical needs of patients. The Company's current development pipeline includes a glucokinase activator, which is Phase II ready for autoimmune diseases including uveitis, Hashimoto's Thyroiditis, preterm labor, and renal transplant rejection. The Company's development pipeline also includes a potent, irreversible inhibitor of human Myeloperoxidase (MPO) that has the potential to treat idiopathic male infertility.
See More
Previous Close:
$0.9744
Open:
$0.98
24h Volume:
900.70K
Relative Volume:
0.28
Market Cap:
$5.51M
Revenue:
-
Net Income/Loss:
$-4.21M
P/E Ratio:
-16.24
EPS:
-0.0548
Net Cash Flow:
-
1W Performance:
-19.09%
1M Performance:
-24.58%
6M Performance:
-93.34%
1Y Performance:
-99.72%
1-Day Range:
Value
$0.83
$1.00
1-Week Range:
Value
$0.83
$1.135
52-Week Range:
Value
$0.83
$392.00

Conduit Pharmaceuticals Inc Stock (CDT) Company Profile

Name
Name
Conduit Pharmaceuticals Inc
Name
Phone
(646) 491 9132
Name
Address
4851 TAMIAMI TRAIL NORTH, NAPLES
Name
Employee
7
Name
Twitter
Name
Next Earnings Date
Name
Latest SEC Filings
Name
CDT's Discussions on Twitter

Compare CDT with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
CDT
Conduit Pharmaceuticals Inc
0.89 5.51M 0 -4.21M 0 -0.0548
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
512.52 130.83B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
672.36 73.16B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
619.97 37.89B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
253.44 32.28B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
266.26 28.52B 3.81B -644.79M -669.77M -6.24

Conduit Pharmaceuticals Inc Stock (CDT) Latest News

pulisher
10:48 AM

Conduit Pharma Highlights Progress In Lupus Studies, Phase II Trial For AZD1656 - Nasdaq

10:48 AM
pulisher
08:53 AM

Conduit Pharmaceuticals progresses in autoimmune drug studies - Investing.com

08:53 AM
pulisher
08:45 AM

Conduit Pharmaceuticals Provides Research and Development Update on Progress for Pipeline Assets AZD1656, AZD5658, and AZD5904 - The Manila Times

08:45 AM
pulisher
08:30 AM

Conduit's Triple-Drug Pipeline Shows Promise for Lupus TreatmentMajor R&D Breakthrough - StockTitan

08:30 AM
pulisher
Mar 07, 2025

Is Conduit Pharmaceuticals Inc. (CDT) the Best Micro Cap Stock to Buy Now? - Insider Monkey

Mar 07, 2025
pulisher
Mar 06, 2025

Conduit Pharmaceuticals Gets Nasdaq Extension, Plans Capital Market Transfer -March 06, 2025 at 10:42 am EST - Marketscreener.com

Mar 06, 2025
pulisher
Mar 06, 2025

Conduit Pharmaceuticals Provides Update on Nasdaq Stock Market Hearing Panel - The Manila Times

Mar 06, 2025
pulisher
Mar 06, 2025

Conduit Pharmaceuticals secures Nasdaq extension - Investing.com

Mar 06, 2025
pulisher
Mar 06, 2025

Conduit Pharmaceuticals Secures Extension for Nasdaq Compliance Following Bid Price Regaining - Nasdaq

Mar 06, 2025
pulisher
Mar 06, 2025

Can Conduit Pharmaceuticals Keep Its Nasdaq Listing? Critical Deadlines Ahead - StockTitan

Mar 06, 2025
pulisher
Mar 06, 2025

Conduit Pharmaceuticals secures Nasdaq extension By Investing.com - Investing.com Australia

Mar 06, 2025
pulisher
Mar 04, 2025

Conduit Pharmaceuticals Inc (NASDAQ: CDT) Is Down -83.09% So Far This Year: What Will Happen Next? - Stocks Register

Mar 04, 2025
pulisher
Mar 01, 2025

Conduit Pharmaceuticals Inc. (NASDAQ:CDT) Short Interest Update - Defense World

Mar 01, 2025
pulisher
Feb 27, 2025

Taking a look at what insiders are doing to gauge the Conduit Pharmaceuticals Inc (CDT)’s direction - Knox Daily

Feb 27, 2025
pulisher
Feb 20, 2025

Conduit Pharmaceuticals Advances Phase II AI Collaboration With Sarborg To Enhance Drug Development - Nasdaq

Feb 20, 2025
pulisher
Feb 20, 2025

Conduit Progresses Phase II of its AI Initiative with Sarborg - The Manila Times

Feb 20, 2025
pulisher
Feb 20, 2025

How Conduit's New AI System Could Revolutionize Drug Development Decision-Making - StockTitan

Feb 20, 2025
pulisher
Feb 19, 2025

Conduit Pharmaceuticals acts to regain Nasdaq compliance By Investing.com - Investing.com South Africa

Feb 19, 2025
pulisher
Feb 19, 2025

Conduit Pharmaceuticals acts to regain Nasdaq compliance - Investing.com India

Feb 19, 2025
pulisher
Feb 19, 2025

Conduit Pharmaceuticals Files For Offering Of Up To $17.8 Million Of Shares Of Common StockSEC Filing - Marketscreener.com

Feb 19, 2025
pulisher
Feb 18, 2025

Understanding the Risks of Investing in Conduit Pharmaceuticals Inc (CDT) - Knox Daily

Feb 18, 2025
pulisher
Feb 18, 2025

Conduit Pharmaceuticals to execute 1-for-100 reverse stock split - MSN

Feb 18, 2025
pulisher
Feb 17, 2025

Conduit Pharmaceuticals enacts reverse stock split to meet Nasdaq standards - MSN

Feb 17, 2025
pulisher
Feb 13, 2025

Conduit Pharmaceuticals, Charles River Laboratories Partner to Evaluate Potential Lupus Treatment - Marketscreener.com

Feb 13, 2025
pulisher
Feb 13, 2025

Conduit Pharmaceuticals Partners with Charles River in Clinically Relevant Systemic Lupus Erythematosus Model - The Manila Times

Feb 13, 2025
pulisher
Feb 13, 2025

Major Lupus Breakthrough? Conduit Teams Up with Charles River for Game-Changing Treatment Study - StockTitan

Feb 13, 2025
pulisher
Feb 13, 2025

Weekly TechBio News 🤹 - substack.com

Feb 13, 2025
pulisher
Feb 12, 2025

Conduit Pharmaceuticals announces debt repayment and partial conversion of senior secured note - MSN

Feb 12, 2025
pulisher
Feb 12, 2025

Small Cap Stocks To Watch NowFebruary 09th - MarketBeat

Feb 12, 2025
pulisher
Feb 11, 2025

Promising Small Cap Stocks To Keep An Eye OnFebruary 07th - MarketBeat

Feb 11, 2025
pulisher
Feb 11, 2025

Conduit Pharmaceuticals settles debt, converts senior note - MSN

Feb 11, 2025
pulisher
Feb 11, 2025

Conduit Pharmaceuticals Announces Debt Repayment and Partial Conversion of Senior Secured Note - The Manila Times

Feb 11, 2025
pulisher
Feb 11, 2025

Conduit Pharmaceuticals settles debt, converts senior note By Investing.com - Investing.com Australia

Feb 11, 2025
pulisher
Feb 11, 2025

What is Conduit Pharmaceuticals Inc (CDT) Stock Return on Shareholders’ Capital? - SETE News

Feb 11, 2025
pulisher
Feb 11, 2025

Conduit, MGO Global, and Cyclo Therapeutics: Penny Stocks to Watch This Week - PUNE.NEWS

Feb 11, 2025
pulisher
Feb 11, 2025

3 Penny Stocks to Watch Now, 2/11/25 - TipRanks

Feb 11, 2025
pulisher
Feb 10, 2025

Conduit Pharmaceuticals Inc [CDT] is -58.45% lower this YTD. Is it still time to buy? - The DBT News

Feb 10, 2025
pulisher
Feb 10, 2025

CDT’s price-to-cash ratio: Is it a good investment at the moment? - US Post News

Feb 10, 2025
pulisher
Feb 10, 2025

Biotech Alert: Searches spiking for these stocks today - TipRanks

Feb 10, 2025
pulisher
Feb 10, 2025

12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga

Feb 10, 2025
pulisher
Feb 08, 2025

Revolutionizing AI Investment: Why Conduit Pharmaceuticals is a Stock to Watch! - Jomfruland.net

Feb 08, 2025
pulisher
Feb 08, 2025

Conduit Pharmaceuticals Inc. (CDT) Advances AI-Driven Drug Development to Phase II - Insider Monkey

Feb 08, 2025
pulisher
Feb 07, 2025

Conduit Pharmaceuticals (NASDAQ:CDT) Stock Quotes, Forecast and News Summary - Benzinga

Feb 07, 2025
pulisher
Feb 07, 2025

12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga

Feb 07, 2025
pulisher
Feb 07, 2025

Dow Dips 400 Points; US Adds Fewer Than Expected Jobs - Benzinga

Feb 07, 2025
pulisher
Feb 07, 2025

CDT Stock Price and Chart — NASDAQ:CDT - TradingView

Feb 07, 2025
pulisher
Feb 07, 2025

Stock market news: Conduit Pharmaceuticals +103.87%, Doximity +37.47% among top gainers as corporate earnings surpass investor estimates - Business Upturn

Feb 07, 2025
pulisher
Feb 07, 2025

Stock market today: Conduit Pharmaceuticals +83.87%, Doximity +31.02% among top gainers as more companies release their quarterly earnings - Business Upturn

Feb 07, 2025
pulisher
Feb 07, 2025

Stock Price Rise As Conduit (CDT) Marks Progress In Strategic Alliance - Stocks Telegraph

Feb 07, 2025

Conduit Pharmaceuticals Inc Stock (CDT) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Conduit Pharmaceuticals Inc Stock (CDT) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Nirland Ltd
10% Owner
Oct 04 '24
Sale
0.10
1,368,991
140,458
7,031,009
Nirland Ltd
10% Owner
Oct 07 '24
Sale
0.10
939,009
96,530
6,092,000
Nirland Ltd
10% Owner
Oct 01 '24
Sale
0.11
1,250,000
141,375
10,233,177
Nirland Ltd
10% Owner
Sep 30 '24
Sale
0.12
1,016,823
122,019
11,483,177
Nirland Ltd
10% Owner
Oct 02 '24
Sale
0.10
333,177
34,251
9,900,000
Regan Andrew
Director
Jul 16 '24
Sale
0.32
10,244,392
3,246,448
1,691,727
Regan Andrew
Director
Jul 17 '24
Sale
0.26
1,514,100
391,092
177,627
Regan Andrew
Director
Jul 12 '24
Sale
0.25
1,389,820
343,425
12,941,319
Regan Andrew
Director
Jul 11 '24
Sale
0.29
882,952
260,253
14,331,139
Regan Andrew
Director
Jul 15 '24
Sale
0.25
1,005,200
248,385
11,936,119
$78.94
price up icon 2.53%
$318.85
price up icon 1.51%
$20.11
price up icon 1.41%
$33.41
price up icon 0.00%
$99.27
price up icon 0.31%
biotechnology ONC
$266.26
price up icon 1.87%
Cap:     |  Volume (24h):